Registry for Long-term Follow-up of Safety and Efficacy Parameters of GBG Study Participants
Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY
The ETERNITY study is an international, multicenter, observational study that aims to follow up patients who have participated in a GBG trial for early breast cancer, even after the study has officially ended, in order to collect long-term data on survival, late or delayed adverse events, in addition to information related to pregnancy, fertility and other parameters impacting quality of life.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Participation and treatment in a GBG clinical trial for early breast cancer.
• Prospective registration: Written informed consent according to local regulatory requirements prior to data and biomaterial collection.
Locations
Other Locations
Austria
MUI - Univ. Klinik f. Frauenheilkunde Innsbruck
RECRUITING
Innsbruck
Ordensklinikum Linz GmbH - BHS
RECRUITING
Linz
LKH Salzburg - PMU
RECRUITING
Salzburg
Contact Information
Primary
Thomas Ballhausen, Dr.
eternity@gbg.de
0049610274800
Time Frame
Start Date: 2022-10-12
Estimated Completion Date: 2030-05-19
Participants
Target number of participants: 400
Related Therapeutic Areas
Sponsors
Leads: GBG Forschungs GmbH